Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL
Open Access
- 14 May 2015
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 2 (7) , 649-659
Abstract
No abstract availableKeywords
Funding Information
- DHHS (R43CA177067)
- National Cancer Institute
- DHHS (P30CA014089, U01-CA-151837, R01CA-154471, R21-CA-164098)
- National Cancer Institute
- V-Foundation
- Nautica Triathlon
- Ronald McDonald House Charities of Southern California
- NSF-CHE (1308485)
- NIH (1DP2OD007246)
This publication has 25 references indexed in Scilit:
- Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand×Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-resistant B-precursor Acute Lymphoblastic Leukemia in MiceEBioMedicine, 2015
- CD22ΔE12 as a molecular target for RNAi therapyBritish Journal of Haematology, 2015
- A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignanciesEBioMedicine, 2014
- A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint RegulatorEBioMedicine, 2014
- Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemiaBlood, 2013
- Supramolecular Self‐Assembled Nanoparticles Mediate Oral Delivery of Therapeutic TNF‐α siRNA against Systemic InflammationAngewandte Chemie International Edition, 2013
- Reactive and Bioactive Cationic α‐Helical Polypeptide Template for Nonviral Gene DeliveryAngewandte Chemie International Edition, 2011
- Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategiesBlood, 2011
- CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemiaProceedings of the National Academy of Sciences, 2010
- Gene Therapy Progress and Prospects: Reprograming gene expression by trans-splicingGene Therapy, 2005